Menopause

Menopause Company Bonafide Acquires SAM-e Nutritional Technology

Bonafide, the women’s healthcare company focused on introducing a more natural approach to managing menopause symptoms with first-of-its-kind, evidence-based, OTC medical products, has acquired a patented, enhanced formulation of S-adenosylmethionine (SAM-e), with triple the bioavailability of competitor products. This acquisition boosts Bonafide’s patent holdings to more than 50 issued and pending patents that it owns or exclusively licenses and exemplifies its strategy…

Menopaue Support App Balance Adds New Features to Enable Holistic Care

Menopause support app balance has introduced balance+ adding new features and content to the original app. Handpicked by leading menopause specialist Dr Louise Newson, balance+ gives women access to specialists and clinicians in the field, who help women optimize their mental health, nutrition, sleep, physical health, sexual health as well as skin and hair. The original balance app is live in over 150 countries and…

Menopause Startup Evernow Adds $28.5M in Series A Funding and Hollywood Star Power to Combat Stigmatization

Just a few days ago Techcrunch asked: “Why aren’t more VCs funding more startups focused on menopause?”. And maybe slowly, but surely the times they are changing as VCs seem to get comfortable with the idea of funding products that target the high-value “female & 40+” demographic. Today following announcements from Vira (£9.2M), HerMD ($10M), and Gameto ($23M) earlier this year we…

Carrot Fertility Adds Menopause and Low Testosterone Support to its Offering

Carrot Fertility, a leading provider of inclusive benefits, is expanding beyond IVF, egg freezing, pregnancy and co as it adds a new suite of services to its offering targeting those going through menopause or struggling with low testosterone. These conditions are most common for people between the ages of 42 and 65. Carrot Fertiliy Co-founder & Chief Medical Officer Asima Ahmad, MD,…

Menopause Startup Vira Health Raises £9.2M to Invest in R&D and Expand to the U.S.

UK-based Menopause startup Vira Health has raised £9.2m in funding led by Octopus Ventures to invest in product development and internationalization. The round was led by Octopus Ventures with participation from existing investors including LocalGlobe, MMC and Amino Collective and Optum Ventures. Last summer Vira Health raised £1.5M in seed funding. Vira Health’s first product Stella, a menopause-focused digital therapeutics, launched last…

Biotech Company Amyris Gets Serious about the Menopause Market with the Acquisition of Menolabs

Amyris, a synthetic biotech company breaking into Clean Health & Beauty, is getting serious about the menopause market with the acquisition on Menolabs, who have developed line of all natural, proprietary supplements focused on treating perimenopause and menopause symptoms as well as a menopause health tracking app, and a community forum. Amyris previously shared its intention of launching a new consumer brand…

Joylux’s Vaginal Wellness Solution vFit Gold Is Now Sold at Premier Luxury Retailer Saks

With over 50% of women experiencing life-changing symptoms such as bladder leakage and dryness due to menopause, top retailer Saks Fifth Avenue is paving the way in offering solutions. Saks delivers a one-of-a-kind shopping experience, featuring an expertly curated assortment and exceptional customer care. They have chosen Joylux to be the first to address these personal issues. Joylux is a leading menopausal…

Gameto Raises $23M to Redefine Reproductive Longevity with Reprogrammed Ovarian Cells

Gameto, a biotechnology startup solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, today announced that it has raised a $20M in Series A funding led by Future Ventures, with participation from Bold Capital Partners, Lux Capital, Plum Alley, TA Ventures, Overwater Ventures, Robert Nelsen and Anne Wojcicki. Gameto also raised $3M in Seed funding in March 2020 from a range of notable investors…